BMRN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Biomarin Pharmaceutical Inc's cash flow from others for the three months ended in Sep. 2016 was $7 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Sep. 2016 was $347 Mil.
Biomarin Pharmaceutical Inc Cash Flow from Others for the trailing twelve months (TTM) ended in Sep. 2016 was -209.956 (Dec. 2015 ) + 4.48 (Mar. 2016 ) + 545.401 (Jun. 2016 ) + 6.77 (Sep. 2016 ) = $347 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Biomarin Pharmaceutical Inc Annual Data
|Cash Flow from Others||-4||-7||3||11||20||14||17||36||-29||-178|
Biomarin Pharmaceutical Inc Quarterly Data
|Cash Flow from Others||12||-56||6||1||28||2||-210||4||545||7|